NCT03038763
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- Perelman Center for Advanced Medicine Philadelphia, Pennsylvania, United States
Clinical trial condition
Communicable Diseases
Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.
9,178 public trials
548 recruiting studies
Communicable Diseases trial results
Completed
The SOLVE-IT National Randomized Trial
NCT00653991
- Conditions
- Behavior, Blood-Borne Infections, Communicable Diseases, +15 more
- Locations
-
- University of Southern California (University Village) Los Angeles, California, United States
NCT02647281
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- GSK Investigational Site London, United Kingdom
- GSK Investigational Site London, United Kingdom
NCT02350907
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Communicable Diseases, +9 more
- Locations
-
- University Hospital of Bern Bern, Switzerland
- Ambulatorium Kanonengasse Zurich, Switzerland
- Checkpoint Zurich Zurich, Switzerland
NCT01686750
- Conditions
- Behavior, Blood-Borne Infections, Communicable Diseases, +20 more
- Locations
-
- YR Gaitonde Center for AIDS Research and Education Chennai, Tamil Nadu, India
NCT02569710
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
- Locations
-
- CAP Research Ltd Phoenix, Mauritius
- Republican Clinical Hospital Chisinau, Moldova
- Auckland Clinical Studies Auckland, New Zealand
- Christchurch Clinical Studies Trust Christchurch, New Zealand
NCT03762772
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
- Locations
-
- Clinical Research Center at Eastern Virginia Medical School (NOT RECRUITING ADDITIONAL SITES) Norfolk, Virginia, United States
NCT02842060
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
- Locations
-
- University of Pennsylvania Philadelphia, Pennsylvania, United States
Completed
Bioequivalence Study of a Fixed-dose Combination (FDC) of Dolutegravir (DTG) and Rilpivirine (RPV)
NCT02741557
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Overland Park, Kansas, United States
NCT03231930
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +11 more
- Locations
-
- Innerspace Collingwood, Victoria, Australia
- Health Works Footscray, Victoria, Australia
- North Richmond Community Health Richmond, Victoria, Australia